相关实验视频

Updated: Sep 13, 2025

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

在体外检验中,研究了在癌细胞和非癌细胞中对与严重COVID-19相关的基因的类固醇效应

Adriana Kapustová¹, Patrik Macášek¹, Bibiána Baďurová^1,2

¹Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia.

|July 29, 2025

概括

通过影响免疫反应基因,他类药物可能会影响COVID-19的进展. 虽然它们不会直接改变像ACE2这样的关键COVID-19基因,但它们会影响涉及炎症和病毒持久性的途径.

科学领域:

分子生物学分子生物学
药理学药理学是指药理学的学科.
病毒学病毒学

背景情况:

患有肥胖,糖尿病,心血管疾病或高血压的个人有更高的风险严重的COVID-19.
在这些高危人群中,他类药物通常用于高胆固醇血症.
类他类药物除了降低胆固醇之外,还具有性作用,可能影响病毒性疾病.

研究的目的:

研究所有八种现有的他类药物对与复杂的COVID-19相关的基因的影响.
分析他类药物对APOE,ACE2,先天性抗病毒免疫力和呼吸衰竭基因等基因的影响.

主要方法:

从胰腺癌细胞 (MiaPaCa-2) 中重新分析现有的全基因组DNA微阵列数据.
从脂肪组织衍生的介质干细胞 (AD-MSC) 中重新分析现有的全转录组数据.
对与COVID-19严重程度相关的他类药物改变基因表达的集中分析.

主要成果:

在APOE,ACE2或呼吸衰竭相关基因中没有观察到因他类药物引起的变化.
一些他类药物改变了与关键COVID-19相关蛋白质相互作用的基因的表达.
有效的他类药物在体外调节了IL-6,IL-8和NF-kB的相互作用伙伴的表达,可能会影响病毒的持续性.

结论:

类他类药物同时调节多个生物途径.
这些途径包括可能支持的途径和可能抑制COVID-19进展的途径.
类药物对COVID-19的净效应需要进一步调查.

关键词:

在ACE2中,ACE2是ACE2.在这里,APOEOE是APOE.在 COVID-19 疫情中,基因表达的基因表达方式微阵列分析分析类药物类药物类药物

更多相关视频

DNA Vector-based RNA Interference to Study Gene Function in Cancer

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Assessing Specificity of Anticancer Drugs In Vitro

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

相关概念视频

Mechanisms of Retrovirus-induced Cancers

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...